Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

CD19-Targeting CAR T Cells for Myositis and Interstitial Lung Disease Associated With Antisynthetase Syndrome
Ann‐Christin Pecher, Luca Hensen, Reinhild Klein, et al.
JAMA (2023) Vol. 329, Iss. 24, pp. 2154-2154
Open Access | Times Cited: 116

Showing 1-25 of 116 citing articles:

CD19 CAR T-Cell Therapy in Autoimmune Disease — A Case Series with Follow-up
Fabian Müller, Jule Taubmann, Laura Bucci, et al.
New England Journal of Medicine (2024) Vol. 390, Iss. 8, pp. 687-700
Closed Access | Times Cited: 316
Allogeneic CD19-targeted CAR-T therapy in patients with severe myositis and systemic sclerosis
Xiaobing Wang, Xinyu Wu, Binghe Tan, et al.
Cell (2024) Vol. 187, Iss. 18, pp. 4890-4904.e9
Closed Access | Times Cited: 58
Anti-MDA5 antibody-positive dermatomyositis: pathogenesis and clinical progress
Xin Lu, Qinglin Peng, Guochun Wang
Nature Reviews Rheumatology (2023) Vol. 20, Iss. 1, pp. 48-62
Closed Access | Times Cited: 54
Advancements and challenges in CAR T cell therapy in autoimmune diseases
Georg Schett, Fabian Müller, Jule Taubmann, et al.
Nature Reviews Rheumatology (2024) Vol. 20, Iss. 9, pp. 531-544
Closed Access | Times Cited: 39
Innovative cellular therapies for autoimmune diseases: expert-based position statement and clinical practice recommendations from the EBMT practice harmonization and guidelines committee
Raffaella Greco, Tobias Alexander, Nicoletta Del Papa, et al.
EClinicalMedicine (2024) Vol. 69, pp. 102476-102476
Open Access | Times Cited: 31
Chimeric antigen receptor T cell therapy for autoimmune disease
James Chung, Jennifer N. Brudno, Dominic Borie, et al.
Nature reviews. Immunology (2024)
Closed Access | Times Cited: 29
CD19-CAR T-cell therapy induces deep tissue depletion of B cells
Carlo Tur, Markus Eckstein, Joachim Velden, et al.
Annals of the Rheumatic Diseases (2024) Vol. 84, Iss. 1, pp. 106-114
Open Access | Times Cited: 27
Single-cell analysis of refractory anti-SRP necrotizing myopathy treated with anti-BCMA CAR-T cell therapy
Chuan Qin, Minghao Dong, Luo‐Qi Zhou, et al.
Proceedings of the National Academy of Sciences (2024) Vol. 121, Iss. 6
Open Access | Times Cited: 26
Mechanisms underlying dose-limiting toxicities of conventional chemotherapeutic agents
Mohammad Amin Manavi, Mohammad Hosein Fathian Nasab, Razieh Mohammad Jafari, et al.
Journal of Chemotherapy (2024) Vol. 36, Iss. 8, pp. 623-653
Closed Access | Times Cited: 18
Application of blinatumomab, a bispecific anti-CD3/CD19 T-cell engager, in treating severe systemic sclerosis: A case study
Marion Subklewe, Giulia Magno, Christina Gebhardt, et al.
European Journal of Cancer (2024) Vol. 204, pp. 114071-114071
Open Access | Times Cited: 18
B-cell depletion in autoimmune diseases
Georg Schett, György Nagy, Gerhard Krönke, et al.
Annals of the Rheumatic Diseases (2024), pp. ard-225727
Closed Access | Times Cited: 17
Target product profile for cell-based and gene-based therapies to achieve a cure for HIV
Sharon R. Lewin, Cathy Bansbach, Dominic Kemps, et al.
The Lancet HIV (2025) Vol. 12, Iss. 2, pp. e154-e162
Closed Access | Times Cited: 2
CAR T cells for treating autoimmune diseases
Ulrich Blache, Sandy Tretbar, Ulrike Koehl, et al.
RMD Open (2023) Vol. 9, Iss. 4, pp. e002907-e002907
Open Access | Times Cited: 39
CD19 Chimeric Antigen Receptor T Cell Treatment: Unraveling the Role of B Cells in Systemic Lupus Erythematosus
Jule Taubmann, Fabian Müller, Melek Yalçın Mutlu, et al.
Arthritis & Rheumatology (2023) Vol. 76, Iss. 4, pp. 497-504
Open Access | Times Cited: 25
Successful use of anti-CD19 CAR T cells in severe treatment-refractory stiff-person syndrome
Simon Faissner, Jeremias Motte, Melissa Sgodzai, et al.
Proceedings of the National Academy of Sciences (2024) Vol. 121, Iss. 26
Open Access | Times Cited: 15
Advancing Autoimmune Rheumatic Disease Treatment: CAR-T Cell Therapies - Evidence, Safety, and Future Directions
Ryunosuke Ohno, Akihiro Nakamura
Seminars in Arthritis and Rheumatism (2024) Vol. 67, pp. 152479-152479
Open Access | Times Cited: 13
Frontiers in CAR-T cell therapy for autoimmune diseases
Yan-Ruide Li, Zibai Lyu, Yuning Chen, et al.
Trends in Pharmacological Sciences (2024) Vol. 45, Iss. 9, pp. 839-857
Open Access | Times Cited: 13
The potential and promise for clinical application of adoptive T cell therapy in cancer
Yinqi Li, Yeteng Zheng, Taiqing Liu, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 12
Sequential immunotherapy: towards cures for autoimmunity
Francisco Ramírez‐Valle, Joseph Maranville, Sophie Roy, et al.
Nature Reviews Drug Discovery (2024) Vol. 23, Iss. 7, pp. 501-524
Closed Access | Times Cited: 12
Autologous CD19‐ targeting CAR T cells in refractory juvenile dermatomyositis
Rebecca Nicolai, Pietro Merli, Patricia Morán Álvarez, et al.
Arthritis & Rheumatology (2024)
Closed Access | Times Cited: 12
The therapeutic potential of immunoengineering for systemic autoimmunity
David A. McBride, Ryan M. Jones, Nunzio Bottini, et al.
Nature Reviews Rheumatology (2024) Vol. 20, Iss. 4, pp. 203-215
Closed Access | Times Cited: 9
Current and emerging pharmacotherapies for cytokine release syndrome, neurotoxicity, and hemophagocytic lymphohistiocytosis-like syndrome due to CAR T cell therapy
Zandra E. Walton, Matthew J. Frigault, Marcela V. Maus
Expert Opinion on Pharmacotherapy (2024) Vol. 25, Iss. 3, pp. 263-279
Closed Access | Times Cited: 9
A Review of Antisynthetase Syndrome-Associated Interstitial Lung Disease
Puja Patel, Jenna M. Marinock, A. Ajmeri, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 8, pp. 4453-4453
Open Access | Times Cited: 9
Engineering strategies to safely drive CAR T-cells into the future
Matteo Rossi, Eytan Breman
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 9
Safety and efficacy of CAR-T cell therapy in patients with autoimmune diseases: a systematic review
Lakshmi Prasanna Vaishnavi Kattamuri, Bhavesh Mohan Lal, Nikhil Vojjala, et al.
Rheumatology International (2025) Vol. 45, Iss. 1
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top